In contrast, tumor margins are enriched with CD103+ tissue-resident memory T cells (Trm) associated with favorable patient prognosis, while the immunosuppressive and hypoxic tumor core drives T cells towards terminal exhaustion, reinforced by persistent antigen exposure (13–15). The gene discussed is ITGAE; the disease is neoplasm.